Netherlands
# |
Name |
EBIT Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
0.05%
|
Dec. 31, 2023 | USD 127.21 | -1.46% |
|
Netherlands |
|
2 |
-2.47%
|
Dec. 31, 2023 | USD 8.76 | -0.46% |
|
Netherlands |
|
3 |
-24.76%
|
Dec. 31, 2023 | USD 662.53 | -0.67% |
|
Netherlands |
|
4 |
-356.22%
|
Dec. 31, 2023 | USD 40.94 | -1.52% |
|
Netherlands |
|
5 |
-408.50%
|
Dec. 31, 2023 | USD 2.12 | -1.40% |
|
Netherlands |
|
6 |
-615.97%
|
Dec. 31, 2023 | USD 0.98 | -1.01% |
|
Netherlands |
|
7 |
-1,386.15%
|
Dec. 31, 2023 | USD 22.29 | 2.39% |
|
Netherlands |
|
8 |
-1,672.66%
|
Dec. 31, 2023 | USD 15.74 | -0.32% |
|
Netherlands |
The Pharmaceuticals company in Netherlands with the highest EBIT Margin is Redcare Pharmacy NV (XETRA: RDC.DE) at 0.05%.
The Pharmaceuticals company in Netherlands with the lowest EBIT Margin is uniQure N.V. (NasdaqGS: QURE) at -1,672.66%.
The top 10 Pharmaceuticals companies in Netherlands by EBIT Margin are Redcare Pharmacy NV, Pharming Group N.V., argenx SE, Merus N.V., ProQR Therapeutics N.V., LAVA Therapeutics N.V., NewAmsterdam Pharma Company N.V. and uniQure N.V..
The bottom 10 Pharmaceuticals companies in Netherlands by EBIT Margin are uniQure N.V., NewAmsterdam Pharma Company N.V., LAVA Therapeutics N.V., ProQR Therapeutics N.V., Merus N.V., argenx SE, Pharming Group N.V. and Redcare Pharmacy NV.